Showing results (301-310 of 1,811) with videos related to
Sort By:
Pageof 182
Transplantation and Cellular Therapy|June 13, 2024
Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in MyelomaWilliam Wesson, Danai Dima, Nahid Suleman, et al.Transplantation and Cellular Therapy|June 13, 2024
Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) TherapyScott R Goldsmith, Geoffrey Shouse, F Lennie Wong, et al.Transplantation and Cellular Therapy|June 13, 2024
Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in SpainMi Kwon, Ignacio Gómez-Centurión, Gillen Oarbeascoa, et al.Transplantation and Cellular Therapy|June 13, 2024
Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient OutcomesYung-Tsi Bolon, Rasha Atshan, Mariam Allbee-Johnson, et al.Transplantation and Cellular Therapy|June 15, 2024
Impact of Graft-Versus-Host Disease on Relapse and Nonrelapse Mortality Following Posttransplant Cyclophosphamide-Based TransplantationScott R Solomon, Lizamarie Bachier-Rodriguez, Asad Bashey, et al.Transplantation and Cellular Therapy|November 16, 2023
HLA Class I Allele Loss and Bone Marrow Transplantation Outcomes in Immune Aplastic AnemiaYoshitaka Zaimoku, Takamasa Katagiri, Noriharu Nakagawa, et al.Transplantation and Cellular Therapy|November 20, 2023
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor AllograftJessica S Little, Rémy Duléry, Roman M Shapiro, et al.Transplantation and Cellular Therapy|October 24, 2023
Incidence and Role of Recipient-Specific Antibodies in Allogeneic Hematopoietic Cell Transplantation from Mismatched Related DonorsAlicja Sadowska-Klasa, Anna Dukat-Mazurek, Hanna Zielińska, et al.Transplantation and Cellular Therapy|October 22, 2023
Progress and Pitfalls of Chimeric Antigen Receptor T Cell Immunotherapy against T Cell MalignanciesMathew G Angelos, Ruchi P Patel, Marco Ruella, et al.Transplantation and Cellular Therapy|November 1, 2023
Chimeric Antigen Receptor T Cell Therapy for Myeloma: Where Are We Now and What Is Needed to Move Chimeric Antigen Receptor T Cells Forward to Earlier Lines of Therapy? Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyLarry D Anderson, Binod Dhakal, Tania Jain, et al.Pageof 182